Cached score snapshot

US.WAT · Waters Corporation

110分制 60.1/110;5D動能v2 19/50;排序分 79.1/160

Ranking score 79.1/160
Main score 60.1/110
5D momentum v2 19/50
Rank #63
Setup grade B 71.8

Score breakdown

觀望

Medium twelvedata

Score and price trend

B 71.8 Money flow A · lift 1.27x

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 08-05 09-08 10-09 11-11 12-09 $377.95$456.15$534.36 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling calibration best · score 2.541 · anchors 120 +1.22% -0.34% / +3.74% 72.5% 0% Actual outcome pending · 1 / 3 bars observed
30D observation -1.28% -8.07% / +4.85% 45% 42.5% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.75% -0.84% / +2.97% 63.1% 3.1% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-08-05 → 2026-12-09 · 90 archived points · 2 Improving turn signal · 10 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 79.1
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 60.1/110 (觀望)
5D momentum v2 19/50 (弱)
Score with momentum v2 79.1/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 442.52
ma50 427.74
close 476.88
prevClose 468.55
avgVolume20 908959
volumeRatio 0.96
changePercent 1.78

Metrics snapshot

close 476.88
volume 872487
changePercent 1.78

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 60.1/110
Main rating 觀望
5D momentum v2 19/50
Score with momentum v2 79.1/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.1/5 · 較差

Dimension score 2.1/5
Dimension grade 較差

Sub-items

pbPoints 0.4
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 416.0716
volumePoints 0.5
revenuePoints 0
dividendPoints 0
marketCapPoints 0.5

資金流 — 15.6/20 · 良好

Dimension score 15.6/20
Dimension grade 良好

Sub-items

cmfPoints 2.4
mfiPoints 3.2
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.WAT
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 8.6/15 · 較差

Dimension score 8.6/15
Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 17.52

trend

score 3.4

details

qqq

ma20 732.4765
ma50 725.4244
name QQQ
close 725.61
points 1.4

spy

ma20 770.8955
ma50 767.626
name SPY
close 772.31
points 2
source twelvedata+fred
atrPct 3.0198
atrPoints 2
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 3
catalystCount 0
catalystPoints 2

風險管理 — 6.5/10 · 一般

Dimension score 6.5/10
Dimension grade 一般

Sub-items

position

score 1.3

details

atrPct 3.0198
turnoverUsdM 416.0716
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.WAT
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 448.0786

strength_details

ma_score 1.5
atr_score 1
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 6
take_profit_price 500.724
target_multiplier 1.6
technical_strength 1.5
take_profit_percent 5
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.0395
diversificationPoints 2

技術信號 — 21.3/30 · 良好

Dimension score 21.3/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 2.6
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 2.6
vcp_reason 波幅收縮(11.5%→9%);站上MA50;升放量(近10日3日);收盤突破20日高位;Ready=N;Confirm=Y

vcp_metrics

up_days 5
vol_ref 862750
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 889160
avg_vol_20 898630
avg_vol_30 862750
range_pct_10 0.0899
range_pct_20 0.1033
range_pct_30 0.1152
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 3
breakout_20d_ok true
vol_ratio_10_30 1.0306
dist_to_20d_high -0.0128
down_shrink_days 1
breakout_level_20d 470.86
vcp_breakout_confirm true
contraction_ratio_10_30 0.781
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 0.8

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 3
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.8

sentimentData

raw {"id":143205210,"url":"https://finnhub.io/api/news?id=75ab2cb990a4fbedefee386c5c7a3d8ef379e14f75addf0dabc7fa52c3d45ecc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"The past six months have been a windfall for Waters Corporation’s shareholders. The company’s stock price has jumped 51.7%, hitting $454.91 per share. This performance may have investors wondering how to approach the situation.","category":"company","datetime":1793053367,"headline":"2 Reasons to like WAT and 1 to stay skeptical"}, {"id":143043366,"url":"https://finnhub.io/api/news?id=99fa4d3e0bda26f1959fe16517cc76281572675f289f75fc28627765efbf6b56","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation has logged a powerful run in recent years, and the stock now sits at a level where investors naturally ask whether the current price is in line with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the question is how that cash flow based estimate stacks up against a share price that has already moved a long way. Over the past 3 years Waters has returned 77.7%, which puts real weight on getting the cash flow valuation call...","category":"company","datetime":1792557067,"headline":"Waters (WAT) Stock Looks 26% Overvalued On Cash Flow Estimates"}, {"id":142730063,"url":"https://finnhub.io/api/news?id=b4ec400d9af121f4582219f4a15c82ddddc99f351205421252b72488151aa5e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.","category":"company","datetime":1791465000,"headline":"Here's Why You Should Retain WAT Stock in Your Portfolio for Now"}
raw_source {"id":143262253,"url":"https://finnhub.io/api/news?id=8d25fea46ee0cc3112adfd0ee5609a5a12e264f0889547fba2b572dfeab8e188","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"WAT's Q3 results are likely to benefit from strong revenue growth prospects, rising demand and acquisition gains.","category":"company","datetime":1793206260,"headline":"Waters Gears Up to Report Q3 Results: How to Play the Stock?"}, {"id":143254910,"url":"https://finnhub.io/api/news?id=bd2b8f10f776721595a8d1cf58de4dbe08eb9835bfcc493d0d3b4206e5b56833","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation (NYSE: WAT) today announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine learning, and automation cloud-based capabilities directly into Empower Software, the chromatography data system of record for regulated laboratories worldwide.","category":"company","datetime":1793188800,"headline":"Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software"}, {"id":143238397,"url":"https://finnhub.io/api/news?id=123b58ad24fb079a3b83666a65de7d0245153a3ccc25616bf707bddfad20d273","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.","category":"company","datetime":1793115060,"headline":"Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests"}, {"id":143205210,"url":"https://finnhub.io/api/news?id=75ab2cb990a4fbedefee386c5c7a3d8ef379e14f75addf0dabc7fa52c3d45ecc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"The past six months have been a windfall for Waters Corporation’s shareholders. The company’s stock price has jumped 51.7%, hitting $454.91 per share. This performance may have investors wondering how to approach the situation.","category":"company","datetime":1793053367,"headline":"2 Reasons to like WAT and 1 to stay skeptical"}, {"id":143202820,"url":"https://finnhub.io/api/news?id=dedac7e55ea3388ab12b0603e5f7af2043af8bf6cf9681e120f8b78c8a4ec212","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 31.5% over the past six months while the S&P 500 was up 6.8%.","category":"company","datetime":1793039447,"headline":"1 healthcare stock for long-term investors and 2 we ignore"}, {"id":143201015,"url":"https://finnhub.io/api/news?id=57e35b2bd284eb30a47293b8018e99be671d9e323f6d25cb064a537adbbe968a","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2268513467/image_2268513467.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"WAT","summary":"The First Eagle U.S. Fund reported a 4.36% return for Q3 2026, outperforming the S&P 500. Read the full analysis for more details.","category":"company","datetime":1793017800,"headline":"First Eagle U.S. Value Fund Q3 2026 Portfolio Review"}, {"id":143137585,"url":"https://finnhub.io/api/news?id=1f7fc2368699870e1efc10f9dac10e71ba897dfb55efe711f4aac5b4ccafcac7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Quest Diagnostics (NYSE:DGX) and Waters Corporation announced a collaboration to expand access to the Onclarity Self-Collection Kit for cervical cancer screening. The partnership focuses on at-home sample collection that can be processed through Quest Diagnostics laboratories using the Onclarity HPV assay. The two companies aim to widen access to clinically appropriate cervical cancer testing for patients who face barriers to in clinic screening. The Onclarity Self-Collection Kit...","category":"company","datetime":1792797122,"headline":"Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening"}, {"id":143132441,"url":"https://finnhub.io/api/news?id=9a6fb933e9b47bcf88a1bfbd04036b06b866bce5ba0cce7b0a846ec75f841f01","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026.","category":"company","datetime":1792756800,"headline":"Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026"}, {"id":143134634,"url":"https://finnhub.io/api/news?id=7e3bae8566dd0681484fe4ae49e9584b49998f9e0e75af3901b87b18ecc89c48","image":"","source":"Benzinga","related":"WAT","summary":"Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center,","category":"company","datetime":1792742783,"headline":"Waters And Labcorp To Expand Access To BD Onclarity HPV Assay"}, {"id":143087262,"url":"https://finnhub.io/api/news?id=eba9a293516889b9db11cf3881c5665bd9e741fb9e36f87cf455c1d1c54b430a","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"WAT","summary":"S&P 500 premarket movers on Oct. 21: SMCI, DELL, VRT, LITE, BE and HPE led gainers, while ISRG, NFLX, T, ABT and DHR led declines.","category":"company","datetime":1792586166,"headline":"S&P 500 Premarket Movers on Oct. 21: Tech Hardware and AI Suppliers Gain, Health Care Declines"}, {"id":143043366,"url":"https://finnhub.io/api/news?id=99fa4d3e0bda26f1959fe16517cc76281572675f289f75fc28627765efbf6b56","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation has logged a powerful run in recent years, and the stock now sits at a level where investors naturally ask whether the current price is in line with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the question is how that cash flow based estimate stacks up against a share price that has already moved a long way. Over the past 3 years Waters has returned 77.7%, which puts real weight on getting the cash flow valuation call...","category":"company","datetime":1792557067,"headline":"Waters (WAT) Stock Looks 26% Overvalued On Cash Flow Estimates"}, {"id":143028934,"url":"https://finnhub.io/api/news?id=42fb19fac55354e2499a0acbf2bc8308b27df6ce408c5e6156e04c9f73a7e9cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.","category":"company","datetime":1792502400,"headline":"Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows"}, {"id":143029805,"url":"https://finnhub.io/api/news?id=c270824aac8c817fd6f7f9381a53d4b6e8bb0a1c505153a9ab7ccc2ea7dd14ee","image":"https://image.cnbcfm.com/api/v1/image/108438094-17925143591792514357-49123421093-1080pnbcnews.jpg?v=1792514359&w=1920&h=1080","source":"CNBC","related":"WAT","summary":"Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's \"Halftime Report\" to spotlight Waters Corporation and Thermo Fisher in his \"Best Stocks in the Market.\"","category":"company","datetime":1792500356,"headline":"Josh Brown's \"Best Stocks in the Market:\" Waters and Thermo Fisher"}, {"id":143023828,"url":"https://finnhub.io/api/news?id=f54cdd1ff502cc03ae8cc6fa900a19470b9424c6f9b04dad5cc253b2ff8355f1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a collaboration intended to broaden access to clinically appropriate at-home cervical cancer screening through the FDA-cleared Onclarity™ Self-Collection Kit.1,2,13","category":"company","datetime":1792497600,"headline":"Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option"}, {"id":143010668,"url":"https://finnhub.io/api/news?id=9682767f5944a8ea16d51193bbbb60c91179082a7ddd93cf47f710e54a272e0e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation is all geared up to release its third-quarter earnings next month, and analysts anticipate a double-digit boost in its profitability.","category":"company","datetime":1792416569,"headline":"Earnings Preview: What to Expect From Waters Corporation’s Report"}, {"id":142997770,"url":"https://finnhub.io/api/news?id=ab33f6812a39173b4bbf8ed1420620525807eec66531b4c62963c1ee560e41ed","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"LONDON, October 19, 2026--IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company using its High Definition Immunology™ platform to better understand the immune system and drive a shift in how we understand, diagnose, and treat disease, has today announced a new collaboration with UK Biobank to generate large-scale multi-omic immune profiling data from 80,000 blood samples collected from UK Biobank participants.","category":"company","datetime":1792393680,"headline":"IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease"}, {"id":142997771,"url":"https://finnhub.io/api/news?id=808170f23fc379497c6b8a60ecfb66493710c5f63b2904675d23968f8632c6b4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Ultima Genomics, Inc., developer of ultra-high-throughput next-generation sequencing (NGS) platforms, today announced that its recently launched UG200 Sequencing Platform has been selected to power a new large-scale immune profiling study with IMU Biosciences and UK Biobank. The study will generate one of the most detailed pictures of the human immune system assembled to date, adding a high-resolution immune data layer and a foundational dataset for AI to UK Biobank, one of the world's most impo","category":"company","datetime":1792393500,"headline":"Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation"}, {"id":142945309,"url":"https://finnhub.io/api/news?id=5040160360ff4c52ef340a2bb9f579c9f01e9f273c2f8bb5c296d5105ee48fa6","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536","source":"Benzinga","related":"WAT","summary":"Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 11.7%. Currently, Waters has a market capitalization of $42.17 billion. \nBuying","category":"company","datetime":1792082731,"headline":"Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years"}, {"id":142966507,"url":"https://finnhub.io/api/news?id=2d2d13366651733cb1b6145af866a2a92742630d55dba52d18f49e1906822cb7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation (NYSE: WAT) today announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context Protocol (MCP) to its informatics platform and has joined Anthropic's Model Hardware Standard (MHS) research program.","category":"company","datetime":1791892800,"headline":"Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release"}, {"id":142883797,"url":"https://finnhub.io/api/news?id=c3d7953d6a5d896f03542e49db2c603dc931f592f1870598f157171386a6fa0b","image":"","source":"Benzinga","related":"WAT","summary":"TD Cowen analyst Dan Brennan maintains Waters (NYSE:WAT) with a Buy and raises the price target from $475 to $515.","category":"company","datetime":1791892541,"headline":"TD Cowen Maintains Buy on Waters, Raises Price Target to $515"}, {"id":142730063,"url":"https://finnhub.io/api/news?id=b4ec400d9af121f4582219f4a15c82ddddc99f351205421252b72488151aa5e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.","category":"company","datetime":1791465000,"headline":"Here's Why You Should Retain WAT Stock in Your Portfolio for Now"}, {"id":142728490,"url":"https://finnhub.io/api/news?id=6c2f069d7813e573b0ce8d7ac211fac811097d76de78e6fe7f5c54ae9933a351","image":"","source":"Benzinga","related":"WAT","summary":"Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $460 to $500.","category":"company","datetime":1791373046,"headline":"Barclays Maintains Overweight on Waters, Raises Price Target to $500"}, {"id":142695692,"url":"https://finnhub.io/api/news?id=85c2474c0ddb084841e4c085e22b2a859b346cac22eac3c0e8722cd9d7ee988a","image":"https://cdn.benzinga.com/files/images/story/2026/10/07/SP-500-Set-To-Surge-Like-Never-Before-Be.jpg?width=2048&height=1536","source":"Benzinga","related":"WAT","summary":"Micron, Sandisk and Nvidia lead seven S&P 500 stocks that more than doubled quarterly revenue. Six sell AI hardware.","category":"company","datetime":1791367570,"headline":"Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth"}, {"id":142694485,"url":"https://finnhub.io/api/news?id=205ddd44ff6f1452e358342025e56e33cb0dfa365f5e2fbc16991e2a8a53e86d","image":"https://cdn.benzinga.com/files/images/story/2026/10/06/Golden-Bull-Figurine-In-Foreground-With-.jpg?width=2048&height=1536","source":"Benzinga","related":"WAT","summary":"The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member trades 25% below its own peak.","category":"company","datetime":1791300578,"headline":"The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited"}, {"id":142662145,"url":"https://finnhub.io/api/news?id=39eb1cdfec2b24808a3835bbdbb63f47c6b13870f9b4d20c113dec5d245a3d8e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Under the framework, the two organisations will initially focus on flow cytometry-based programmes.","category":"company","datetime":1791282532,"headline":"CellCarta, Waters Corporation collaborate on companion diagnostics"}, {"id":142635380,"url":"https://finnhub.io/api/news?id=628d8c80b6c2955b506f4753f539d2fb80521c012b22fa288d5d3c6b9ca77bc3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framework to jointly pursue companion diagnostic (CDx) and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.","category":"company","datetime":1791206100,"headline":"CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development"}, {"id":142633835,"url":"https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"WAT","summary":"First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.","category":"company","datetime":1791185457,"headline":"FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"}, {"id":142557975,"url":"https://finnhub.io/api/news?id=7c585765141d5585e6d79175cfa3839c39250530199bd4ad81048f0ffa47e24e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 1, 2026, at midnight Eastern Time.","category":"company","datetime":1790859600,"headline":"Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call"}, {"id":142559165,"url":"https://finnhub.io/api/news?id=a369a81d6c981559e667e1d316ee895227cc3414ab79c9d2d8a1f5fca1c4fcd3","image":"","source":"Benzinga","related":"WAT","summary":"Guggenheim analyst Subbu Nambi maintains Waters (NYSE:WAT) with a Buy and raises the price target from $440 to $490.","category":"company","datetime":1790848043,"headline":"Guggenheim Maintains Buy on Waters, Raises Price Target to $490"}, {"id":142559166,"url":"https://finnhub.io/api/news?id=54a96966f4bee0ee2424358170e80a4b6330876c9576d750f0ffe11ba9fb481c","image":"https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536","source":"Benzinga","related":"WAT","summary":"Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 11.99%. Currently, Waters has a market capitalization of $43.33 billion. \nBuying","category":"company","datetime":1790795749,"headline":"If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today"}, {"id":142513513,"url":"https://finnhub.io/api/news?id=4ce869aadf41f489c7b7dafd967ff0fd20e41fe2914cacf122b79c047b5490c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"WAT","summary":"Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.","category":"company","datetime":1790762713,"headline":"1 Volatile Stock with Promising Prospects and 2 We Avoid"}
data_source finnhub_news_keyword_model
article_count 3
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.8
source_article_count 31
discarded_article_count 28
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.1 5/110 42% 2.1
資金流 15.6 20/110 78% 15.6
市場環境 8.6 15/110 57.33% 8.6
催化劑 2 20/110 10% 2
風險管理 6.5 10/110 65% 6.5
技術信號 21.3 30/110 71% 21.3
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 19/50
ret_5d 0.0424
max_score 50
max_total 50
raw_total 19
vcp_bonus 0
vol_ratio 0.9709
ret_points 8
vol_points 0
range_ratio 1.1217
volat_points 0
day_range_pct 0.0356
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.3

details

atrPct 3.0198
turnoverUsdM 416.0716
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.WAT
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 448.0786

strength_details

ma_score 1.5
atr_score 1
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 6
take_profit_price 500.724
target_multiplier 1.6
technical_strength 1.5
take_profit_percent 5
positionPoints 1.3
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 6.0395
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.1/5分
資金流分析總分: 15.6/20分
市場環境分析總分: 8.6/15分
催化劑分析: 2/20分
風險管理總分: 6.5/10分
技術信號分析總分: 21.3/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 14.4007
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.02
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 209.79
cmf
rule Cursor_18.24 CMF bands
level 輕微流入
score 6
value 0.1097
kdj
d 75.65
j 99.2
k 83.5
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 入貨中
score 8
value 67.51
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 5104787
recentSlope 76188.7
previousSlope -144040
rsi
value 78.32
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 435.0977
position SAR喺價下
distancePct 8.76
previousTrend 上升
ma50
value 427.74
macd
macd 10.8168
trend 強烈看漲
signal 7.7971
histogram 3.0198
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 442.1293
position 連續5日>VWAP
consecutiveAbove 11
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.96
score 4
avgVolume 908959
currentVolume 872487
derived
ma20 442.52
ma50 427.74
prevClose 468.55
avgVolume10 886269
avgVolume20 908959
changePercent 1.78
avgVolumeForScore 908959
ma_cross
ma20 442.52
ma50 427.74
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 440.6455
prevMa50 426.2274
spreadPct 3.46
isVolumeBreakout false
bollinger
lower 414.5514
upper 470.4886
position 上半部
rsi_short
value 90.88
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.96

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.019774366716994,
        "turnoverUsdM": 416.07160056,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.WAT",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 448.0786,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6,
      "take_profit_price": 500.724,
      "target_multiplier": 1.6,
      "technical_strength": 1.5,
      "take_profit_percent": 5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.039548733433988,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 79.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 19
  },
  "market": {
    "ma20": 442.52,
    "ma50": 427.74,
    "close": 476.88,
    "prevClose": 468.55,
    "avgVolume20": 908959,
    "volumeRatio": 0.96,
    "changePercent": 1.78
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 19,
    "details": {
      "ret_5d": 0.04242901173847469,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 19,
      "vcp_bonus": 0,
      "vol_ratio": 0.9709079376384051,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 1.1216801000554808,
      "volat_points": 0,
      "day_range_pct": 0.035606462841805055,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 79.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 42,
        "contribution": 2.1
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.5,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 65,
        "contribution": 6.5
      },
      {
        "raw": 21.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 71,
        "contribution": 21.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.1,
    "details": [
      "基本面分析總分: 2.1/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.5/10分",
      "技術信號分析總分: 21.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.1,
      "資金流": 15.6,
      "市場環境": 8.6,
      "情緒分析": 4,
      "技術信號": 21.3,
      "風險管理": 6.5
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 3,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 416.07160056,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.WAT",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 17.52
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 732.47650135,
                "ma50": 725.4243990000001,
                "name": "QQQ",
                "close": 725.60999,
                "points": 1.4
              },
              "spy": {
                "ma20": 770.8954959000001,
                "ma50": 767.6259946999999,
                "name": "SPY",
                "close": 772.31,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.019774366716994,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 3,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143205210,
                "url": "https://finnhub.io/api/news?id=75ab2cb990a4fbedefee386c5c7a3d8ef379e14f75addf0dabc7fa52c3d45ecc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "The past six months have been a windfall for Waters Corporation’s shareholders. The company’s stock price has jumped 51.7%, hitting $454.91 per share. This performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1793053367,
                "headline": "2 Reasons to like WAT and 1 to stay skeptical"
              },
              {
                "id": 143043366,
                "url": "https://finnhub.io/api/news?id=99fa4d3e0bda26f1959fe16517cc76281572675f289f75fc28627765efbf6b56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation has logged a powerful run in recent years, and the stock now sits at a level where investors naturally ask whether the current price is in line with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the question is how that cash flow based estimate stacks up against a share price that has already moved a long way. Over the past 3 years Waters has returned 77.7%, which puts real weight on getting the cash flow valuation call...",
                "category": "company",
                "datetime": 1792557067,
                "headline": "Waters (WAT) Stock Looks 26% Overvalued On Cash Flow Estimates"
              },
              {
                "id": 142730063,
                "url": "https://finnhub.io/api/news?id=b4ec400d9af121f4582219f4a15c82ddddc99f351205421252b72488151aa5e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.",
                "category": "company",
                "datetime": 1791465000,
                "headline": "Here's Why You Should Retain WAT Stock in Your Portfolio for Now"
              }
            ],
            "raw_source": [
              {
                "id": 143262253,
                "url": "https://finnhub.io/api/news?id=8d25fea46ee0cc3112adfd0ee5609a5a12e264f0889547fba2b572dfeab8e188",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "WAT's Q3 results are likely to benefit from strong revenue growth prospects, rising demand and acquisition gains.",
                "category": "company",
                "datetime": 1793206260,
                "headline": "Waters Gears Up to Report Q3 Results: How to Play the Stock?"
              },
              {
                "id": 143254910,
                "url": "https://finnhub.io/api/news?id=bd2b8f10f776721595a8d1cf58de4dbe08eb9835bfcc493d0d3b4206e5b56833",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation (NYSE: WAT) today announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine learning, and automation cloud-based capabilities directly into Empower Software, the chromatography data system of record for regulated laboratories worldwide.",
                "category": "company",
                "datetime": 1793188800,
                "headline": "Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software"
              },
              {
                "id": 143238397,
                "url": "https://finnhub.io/api/news?id=123b58ad24fb079a3b83666a65de7d0245153a3ccc25616bf707bddfad20d273",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.",
                "category": "company",
                "datetime": 1793115060,
                "headline": "Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests"
              },
              {
                "id": 143205210,
                "url": "https://finnhub.io/api/news?id=75ab2cb990a4fbedefee386c5c7a3d8ef379e14f75addf0dabc7fa52c3d45ecc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "The past six months have been a windfall for Waters Corporation’s shareholders. The company’s stock price has jumped 51.7%, hitting $454.91 per share. This performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1793053367,
                "headline": "2 Reasons to like WAT and 1 to stay skeptical"
              },
              {
                "id": 143202820,
                "url": "https://finnhub.io/api/news?id=dedac7e55ea3388ab12b0603e5f7af2043af8bf6cf9681e120f8b78c8a4ec212",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 31.5% over the past six months while the S&P 500 was up 6.8%.",
                "category": "company",
                "datetime": 1793039447,
                "headline": "1 healthcare stock for long-term investors and 2 we ignore"
              },
              {
                "id": 143201015,
                "url": "https://finnhub.io/api/news?id=57e35b2bd284eb30a47293b8018e99be671d9e323f6d25cb064a537adbbe968a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2268513467/image_2268513467.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WAT",
                "summary": "The First Eagle U.S. Fund reported a 4.36% return for Q3 2026, outperforming the S&P 500. Read the full analysis for more details.",
                "category": "company",
                "datetime": 1793017800,
                "headline": "First Eagle U.S. Value Fund Q3 2026 Portfolio Review"
              },
              {
                "id": 143137585,
                "url": "https://finnhub.io/api/news?id=1f7fc2368699870e1efc10f9dac10e71ba897dfb55efe711f4aac5b4ccafcac7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Quest Diagnostics (NYSE:DGX) and Waters Corporation announced a collaboration to expand access to the Onclarity Self-Collection Kit for cervical cancer screening. The partnership focuses on at-home sample collection that can be processed through Quest Diagnostics laboratories using the Onclarity HPV assay. The two companies aim to widen access to clinically appropriate cervical cancer testing for patients who face barriers to in clinic screening. The Onclarity Self-Collection Kit...",
                "category": "company",
                "datetime": 1792797122,
                "headline": "Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening"
              },
              {
                "id": 143132441,
                "url": "https://finnhub.io/api/news?id=9a6fb933e9b47bcf88a1bfbd04036b06b866bce5ba0cce7b0a846ec75f841f01",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026.",
                "category": "company",
                "datetime": 1792756800,
                "headline": "Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026"
              },
              {
                "id": 143134634,
                "url": "https://finnhub.io/api/news?id=7e3bae8566dd0681484fe4ae49e9584b49998f9e0e75af3901b87b18ecc89c48",
                "image": "",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center,",
                "category": "company",
                "datetime": 1792742783,
                "headline": "Waters And Labcorp To Expand Access To BD Onclarity HPV Assay"
              },
              {
                "id": 143087262,
                "url": "https://finnhub.io/api/news?id=eba9a293516889b9db11cf3881c5665bd9e741fb9e36f87cf455c1d1c54b430a",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "WAT",
                "summary": "S&P 500 premarket movers on Oct. 21: SMCI, DELL, VRT, LITE, BE and HPE led gainers, while ISRG, NFLX, T, ABT and DHR led declines.",
                "category": "company",
                "datetime": 1792586166,
                "headline": "S&P 500 Premarket Movers on Oct. 21: Tech Hardware and AI Suppliers Gain, Health Care Declines"
              },
              {
                "id": 143043366,
                "url": "https://finnhub.io/api/news?id=99fa4d3e0bda26f1959fe16517cc76281572675f289f75fc28627765efbf6b56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation has logged a powerful run in recent years, and the stock now sits at a level where investors naturally ask whether the current price is in line with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the question is how that cash flow based estimate stacks up against a share price that has already moved a long way. Over the past 3 years Waters has returned 77.7%, which puts real weight on getting the cash flow valuation call...",
                "category": "company",
                "datetime": 1792557067,
                "headline": "Waters (WAT) Stock Looks 26% Overvalued On Cash Flow Estimates"
              },
              {
                "id": 143028934,
                "url": "https://finnhub.io/api/news?id=42fb19fac55354e2499a0acbf2bc8308b27df6ce408c5e6156e04c9f73a7e9cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.",
                "category": "company",
                "datetime": 1792502400,
                "headline": "Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows"
              },
              {
                "id": 143029805,
                "url": "https://finnhub.io/api/news?id=c270824aac8c817fd6f7f9381a53d4b6e8bb0a1c505153a9ab7ccc2ea7dd14ee",
                "image": "https://image.cnbcfm.com/api/v1/image/108438094-17925143591792514357-49123421093-1080pnbcnews.jpg?v=1792514359&w=1920&h=1080",
                "source": "CNBC",
                "related": "WAT",
                "summary": "Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's \"Halftime Report\" to spotlight Waters Corporation and Thermo Fisher in his \"Best Stocks in the Market.\"",
                "category": "company",
                "datetime": 1792500356,
                "headline": "Josh Brown's \"Best Stocks in the Market:\" Waters and Thermo Fisher"
              },
              {
                "id": 143023828,
                "url": "https://finnhub.io/api/news?id=f54cdd1ff502cc03ae8cc6fa900a19470b9424c6f9b04dad5cc253b2ff8355f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a collaboration intended to broaden access to clinically appropriate at-home cervical cancer screening through the FDA-cleared Onclarity™ Self-Collection Kit.1,2,13",
                "category": "company",
                "datetime": 1792497600,
                "headline": "Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option"
              },
              {
                "id": 143010668,
                "url": "https://finnhub.io/api/news?id=9682767f5944a8ea16d51193bbbb60c91179082a7ddd93cf47f710e54a272e0e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation is all geared up to release its third-quarter earnings next month, and analysts anticipate a double-digit boost in its profitability.",
                "category": "company",
                "datetime": 1792416569,
                "headline": "Earnings Preview: What to Expect From Waters Corporation’s Report"
              },
              {
                "id": 142997770,
                "url": "https://finnhub.io/api/news?id=ab33f6812a39173b4bbf8ed1420620525807eec66531b4c62963c1ee560e41ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "LONDON, October 19, 2026--IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company using its High Definition Immunology™ platform to better understand the immune system and drive a shift in how we understand, diagnose, and treat disease, has today announced a new collaboration with UK Biobank to generate large-scale multi-omic immune profiling data from 80,000 blood samples collected from UK Biobank participants.",
                "category": "company",
                "datetime": 1792393680,
                "headline": "IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease"
              },
              {
                "id": 142997771,
                "url": "https://finnhub.io/api/news?id=808170f23fc379497c6b8a60ecfb66493710c5f63b2904675d23968f8632c6b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Ultima Genomics, Inc., developer of ultra-high-throughput next-generation sequencing (NGS) platforms, today announced that its recently launched UG200 Sequencing Platform has been selected to power a new large-scale immune profiling study with IMU Biosciences and UK Biobank. The study will generate one of the most detailed pictures of the human immune system assembled to date, adding a high-resolution immune data layer and a foundational dataset for AI to UK Biobank, one of the world's most impo",
                "category": "company",
                "datetime": 1792393500,
                "headline": "Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation"
              },
              {
                "id": 142945309,
                "url": "https://finnhub.io/api/news?id=5040160360ff4c52ef340a2bb9f579c9f01e9f273c2f8bb5c296d5105ee48fa6",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 11.7%. Currently, Waters has a market capitalization of $42.17 billion. \nBuying",
                "category": "company",
                "datetime": 1792082731,
                "headline": "Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years"
              },
              {
                "id": 142966507,
                "url": "https://finnhub.io/api/news?id=2d2d13366651733cb1b6145af866a2a92742630d55dba52d18f49e1906822cb7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation (NYSE: WAT) today announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context Protocol (MCP) to its informatics platform and has joined Anthropic's Model Hardware Standard (MHS) research program.",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release"
              },
              {
                "id": 142883797,
                "url": "https://finnhub.io/api/news?id=c3d7953d6a5d896f03542e49db2c603dc931f592f1870598f157171386a6fa0b",
                "image": "",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "TD Cowen  analyst Dan Brennan   maintains Waters (NYSE:WAT) with a Buy and raises the price target from $475 to $515.",
                "category": "company",
                "datetime": 1791892541,
                "headline": "TD Cowen Maintains Buy on Waters, Raises Price Target to $515"
              },
              {
                "id": 142730063,
                "url": "https://finnhub.io/api/news?id=b4ec400d9af121f4582219f4a15c82ddddc99f351205421252b72488151aa5e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.",
                "category": "company",
                "datetime": 1791465000,
                "headline": "Here's Why You Should Retain WAT Stock in Your Portfolio for Now"
              },
              {
                "id": 142728490,
                "url": "https://finnhub.io/api/news?id=6c2f069d7813e573b0ce8d7ac211fac811097d76de78e6fe7f5c54ae9933a351",
                "image": "",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Barclays  analyst Luke Sergott   maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $460 to $500.",
                "category": "company",
                "datetime": 1791373046,
                "headline": "Barclays Maintains Overweight on Waters, Raises Price Target to $500"
              },
              {
                "id": 142695692,
                "url": "https://finnhub.io/api/news?id=85c2474c0ddb084841e4c085e22b2a859b346cac22eac3c0e8722cd9d7ee988a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/SP-500-Set-To-Surge-Like-Never-Before-Be.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Micron, Sandisk and Nvidia lead seven S&P 500 stocks that more than doubled quarterly revenue. Six sell AI hardware.",
                "category": "company",
                "datetime": 1791367570,
                "headline": "Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth"
              },
              {
                "id": 142694485,
                "url": "https://finnhub.io/api/news?id=205ddd44ff6f1452e358342025e56e33cb0dfa365f5e2fbc16991e2a8a53e86d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/06/Golden-Bull-Figurine-In-Foreground-With-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member trades 25% below its own peak.",
                "category": "company",
                "datetime": 1791300578,
                "headline": "The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited"
              },
              {
                "id": 142662145,
                "url": "https://finnhub.io/api/news?id=39eb1cdfec2b24808a3835bbdbb63f47c6b13870f9b4d20c113dec5d245a3d8e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Under the framework, the two organisations will initially focus on flow cytometry-based programmes.",
                "category": "company",
                "datetime": 1791282532,
                "headline": "CellCarta, Waters Corporation collaborate on companion diagnostics"
              },
              {
                "id": 142635380,
                "url": "https://finnhub.io/api/news?id=628d8c80b6c2955b506f4753f539d2fb80521c012b22fa288d5d3c6b9ca77bc3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, creating a framework to jointly pursue companion diagnostic (CDx) and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.",
                "category": "company",
                "datetime": 1791206100,
                "headline": "CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development"
              },
              {
                "id": 142633835,
                "url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "WAT",
                "summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
                "category": "company",
                "datetime": 1791185457,
                "headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
              },
              {
                "id": 142557975,
                "url": "https://finnhub.io/api/news?id=7c585765141d5585e6d79175cfa3839c39250530199bd4ad81048f0ffa47e24e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 1, 2026, at midnight Eastern Time.",
                "category": "company",
                "datetime": 1790859600,
                "headline": "Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call"
              },
              {
                "id": 142559165,
                "url": "https://finnhub.io/api/news?id=a369a81d6c981559e667e1d316ee895227cc3414ab79c9d2d8a1f5fca1c4fcd3",
                "image": "",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Guggenheim  analyst Subbu Nambi   maintains Waters (NYSE:WAT) with a Buy and raises the price target from $440 to $490.",
                "category": "company",
                "datetime": 1790848043,
                "headline": "Guggenheim Maintains Buy on Waters, Raises Price Target to $490"
              },
              {
                "id": 142559166,
                "url": "https://finnhub.io/api/news?id=54a96966f4bee0ee2424358170e80a4b6330876c9576d750f0ffe11ba9fb481c",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "WAT",
                "summary": "Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 11.99%. Currently, Waters has a market capitalization of $43.33 billion. \nBuying",
                "category": "company",
                "datetime": 1790795749,
                "headline": "If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 142513513,
                "url": "https://finnhub.io/api/news?id=4ce869aadf41f489c7b7dafd967ff0fd20e41fe2914cacf122b79c047b5490c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "WAT",
                "summary": "Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.",
                "category": "company",
                "datetime": 1790762713,
                "headline": "1 Volatile Stock with Promising Prospects and 2 We Avoid"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 3,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.8,
            "source_article_count": 31,
            "discarded_article_count": 28
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.3,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.6,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.6,
            "vcp_reason": "波幅收縮(11.5%→9%);站上MA50;升放量(近10日3日);收盤突破20日高位;Ready=N;Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 862750,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 889160,
              "avg_vol_20": 898630,
              "avg_vol_30": 862750,
              "range_pct_10": 0.08993874769333995,
              "range_pct_20": 0.10327545713806409,
              "range_pct_30": 0.1151652197617849,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 1.0306114169805853,
              "dist_to_20d_high": -0.012785138104428906,
              "down_shrink_days": 1,
              "breakout_level_20d": 470.85999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.7809540751919287
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.019774366716994,
              "turnoverUsdM": 416.07160056,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.WAT",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 448.0786,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6,
            "take_profit_price": 500.724,
            "target_multiplier": 1.6,
            "technical_strength": 1.5,
            "take_profit_percent": 5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.039548733433988,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 14.4007,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.02
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 209.79
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1097
    },
    "kdj": {
      "d": 75.65,
      "j": 99.2,
      "k": 83.5,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 67.51
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 5104787,
      "recentSlope": 76188.7,
      "previousSlope": -144040
    },
    "rsi": 78.32,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 435.0977,
      "position": "SAR喺價下",
      "distancePct": 8.76,
      "previousTrend": "上升"
    },
    "ma50": 427.74,
    "macd": {
      "macd": 10.816840246865922,
      "trend": "強烈看漲",
      "signal": 7.797076679976087,
      "histogram": 3.0197635668898357
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 442.1293,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 11
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.96,
      "score": 4,
      "avgVolume": 908959,
      "currentVolume": 872487
    },
    "derived": {
      "ma20": 442.52,
      "ma50": 427.74,
      "prevClose": 468.55,
      "avgVolume10": 886269,
      "avgVolume20": 908959,
      "changePercent": 1.78,
      "avgVolumeForScore": 908959
    },
    "ma_cross": {
      "ma20": 442.52,
      "ma50": 427.74,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 440.6455,
      "prevMa50": 426.2274,
      "spreadPct": 3.46,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 414.5514,
      "upper": 470.4886,
      "position": "上半部"
    },
    "rsi_short": 90.88,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.96
    }
  }
}

Raw metrics JSON

{
  "close": 476.88,
  "volume": 872487,
  "changePercent": 1.78
}

Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.